Skip to content

MOERMAN ANN

Active
Private limited companyfounded 200817 yrs activeBayauxlaan 35, 8300 Knokke-Heist, BelgiumKBO/BCE: BE 0808.468.175

MOERMAN ANN has been active since 2008 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €619k and a net result of €82k. Equity is growing by ~20.9% per year across the filed fiscal years. Its solvency ranks better than 86% of 10230 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.5% (low).

Checked score

Score 2025
93 / 100
Excellent= vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability66▼-6
Solvency100=
Growth78=
Stability100
Bankruptcy probability, 12 months
0.5% Low
0%0.5%1.5%4%10%≥ 25%
Credit up to €60k at 30 days acceptable
Liquidity ample (current ratio 3.85 against 4.24 in 2024), and 24.4% of the assets are financed with debt.
Credit advice for your own amount and term

Signals

Six signals. The signal on the left, the evidence on the right.
lowers risk+raises riskneutral
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 47
Relative position
BE, all sectors
reference
Sector 47
higher
← fewer bankruptcies more bankruptcies →
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
75.6%
Return on assets
10%
Age of the figures
8 mo
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
elevated failure risk from 2 to 8 years 17 years 0 20 y
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-04-2026, 93 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
93 d early
2024
6 d late
2023
6 d early
2022
7 d early
2021
3 d early
2020
1 d early
2019
74 d late
← before the deadline after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven months
Position in the running window
13-09-2026 today31-12-2026 close31-07-2027 deadline
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Equity
€619k▲ 4.7%
2024 · €591k
2018: €145k 2019: €175k 2020: €246k 2021: €309k 2022: €404k 2023: €507k 2024: €591k
2018 → 2025
Total assets
€819k▲ 8.4%
2024 · €756k
2018: €566k 2019: €520k 2020: €545k 2021: €572k 2022: €623k 2023: €693k 2024: €756k
2018 → 2025
Net result
€82k▼ 4.2%
2024 · €85k
2018: €34k 2019: €34k 2020: €72k 2021: €63k 2022: €96k 2023: €104k 2024: €85k
2018 → 2025
Working capital
€555k▲ 8.7%
2024 · €511k
2018: €143k 2019: €162k 2020: €194k 2021: €241k 2022: €333k 2023: €431k 2024: €511k
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise ▼ fall
Line20212022202320242025Trend
Equity€309k-€404k▲ 30.8%€507k▲ 25.5%€591k▲ 16.7%€619k▲ 4.7%
Operating result€92k-€146k▲ 58.8%€151k▲ 3.7%€120k▼ 20.6%€109k▼ 9.0%
Net result€63k-€96k▲ 51.2%€104k▲ 8.2%€85k▼ 17.8%€82k▼ 4.2%
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
€0€50k€100k€150kOperating result 2021: €92k€92kNet result 2021: €63k€63kOperating result 2022: €146k€146kNet result 2022: €96k€96kOperating result 2023: €151k€151kNet result 2023: €104k€104kOperating result 2024: €120k€120kNet result 2024: €85k€85kOperating result 2025: €109k€109kNet result 2025: €82k€82k20212022202320242025
The operating result has fallen two years in a row; 2025 is 9% below 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €819k
Fixed assets €70k▼ 20.3%
Current assets €749k▲ 12.1%
Equity and liabilities €819k
Equity €619k▲ 4.7%
Debt €200k▲ 21.5%
The debt ratio rises from 21.8% to 24.4%: debt grows faster than equity.
Key figures and ratios
2025 value · change against 2024
EBITDA
€129k
2024 · €140k
Cash flow
€102k
2024 · €105k
Solvency
75.6%
2024 · 78.2%
Current ratio
3.85
2024 · 4.24
Quick ratio
3.05
2024 · 3.16
Debt / equity
0.32
2024 · 0.28
ROE
13.2%
2024 · 14.4%
ROA
10.0%
2024 · 11.3%
Interest coverage
14.85
2024 · 13.80
Debt
€200k
2024 · €165k
Debt ≤ 1 year
€194k
2024 · €158k
Income taxes
€32k
2024 · €35k
Staff costs
€3k
2024 · €3k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet Code20242025
Assets
Total assets20/58€756k€819k
Fixed assets21/28€88k€70k
Tangible fixed assets22/27€88k€70k
Land and buildings22€77k€61k
Plant, machinery and equipment23€10k€8k
Furniture and vehicles24€677€151
Current assets29/58€668k€749k
Amounts receivable after more than one year29€200k€325k
Other amounts receivable291€200k€325k
Stocks and contracts in progress3€170k€157k
Stocks30/36€170k€157k
Amounts receivable within one year40/41€64k€64k
Trade receivables40€49k€49k
Other amounts receivable41€15k€15k
Current investments50/53€125k-
Cash at bank and in hand54/58€99k€190k
Deferred charges and accrued income490/1€11k€14k
Equity and liabilities
Total equity and liabilities10/49€756k€819k
Equity10/15€591k€619k
Contributions10/11€25k€25k=
Reserves13€551k€579k
Distributable reserves133€551k€579k
Profit (loss) carried forward14€16k€16k=
Amounts payable17/49€165k€200k
Amounts payable within one year42/48€158k€194k
Current portion of amounts payable after more than one year42€27k-
Trade debts44€46k€56k
Suppliers440/4€46k€56k
Taxes, remuneration and social security45€3k€6k
Taxes450/3-€3k
Remuneration and social security454/9€3k€3k
Other amounts payable47/48€82k€132k
Accrued charges and deferred income492/3€7k€6k
Income statement Code20242025
Remuneration, social security and pensions62€3k€3k
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€20k€20k
Other operating charges640/8€4k€5k
Gross operating margin9900€147k€137k
Operating profit (loss)9901€120k€109k
Financial income75/76B€10k€13k
Recurring financial income75€10k€13k
Financial charges65/66B€10k€9k
Recurring financial charges65€10k€9k
Profit (loss) for the period before taxes9903€120k€114k
Income taxes67/77€35k€32k
Profit (loss) for the period9904€85k€82k
Profit (loss) for the period to be appropriated9905€85k€82k
Appropriation of the result
Profit (loss) to be appropriated9906€102k€97k
Profit (loss) brought forward from the previous period14P€16k€16k
Transfer from equity791/2-€53k
Transfer to equity691/2€85k€81k
To other reserves6921€85k€81k
Profit to be distributed694/7€833€54k
Return on contributions (dividend)694€833€54k
Social balance
Average headcount (FTE)90870.10.1=

The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

Next filing, fiscal year 2026, expected by 31-07-2027
2026
29-04
NBB filing Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
06-08
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 6 days late
2024
25-07
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial Highest result since 2018net €104k ▲8.2%
Operating result €151k, net result €104k, both a record.
31-12
Financial Equity above €500kEq €507k ▲25.5%
6 profitable years in a row build equity to €507k.
24-07
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema
2022
28-07
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema
2021
30-07
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
31-12
Financial Equity above €200kEq €246k ▲40.9%
3 profitable years in a row build equity to €246k.
13-10
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 74 days late
2019
31-12
Financial Equity above €150kEq €175k ▲20.4%
2 profitable years in a row build equity to €175k.
31-07
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
17-08
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 17 days late
2017
03-08
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 3 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Knokke-Heist · 1 establishment unit since 2009
establishment The establishment unit on the map
Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Bayauxlaan 358300 Knokke-Heist
Ground area
380 m²
Building footprint
377 m²
Volume, LiDAR
7,048 m³
Parcel 31013A0652/00B000, Flanders · tallest building 22.8 m, ±6 floors. Linked by address, not a title deed.
1 establishment unit
APOTHEEK MOERMAN
Bayauxlaan 35, 8300 Knokke-HeistRetail sale of pharmaceutical products
since 20092.177.232.405
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
31013A0652/00B000 Flanders 380 m² 1 · 377 m² 22.8 m · 6 fl.
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Recognitions · licences · registrations

Food safety, FASFC

1 site
Knokke-Heist2.177.232.405
1 permission
Apotheek (LM>3 maand) · since 07-06-2018

Similar companies · same sector, comparable size

Of 5,208 companies in sector 47730 we hold annual accounts for 3,850. 3,264 are within a factor 10 of this equity.See the whole sector

Company data · Crossroads Bank

Identification
Legal formPrivate limited company
Founded16-12-2008
Fiscal year end31-12
Activities, NACEBEL
47730Retail sale of pharmaceutical products
Sources
Crossroads Bank for EnterprisesNational Bank · 17 filingsAddress and cadastre registers

Data from official sources, last processed on 13-09-2026. Scores and ratios are computed by Checked and are not a credit decision.